Robert Naclerio to Inflammation Mediators
This is a "connection" page, showing publications Robert Naclerio has written about Inflammation Mediators.
Connection Strength
0.230
-
Clinical manifestations of the release of histamine and other inflammatory mediators. J Allergy Clin Immunol. 1999 Mar; 103(3 Pt 2):S382-5.
Score: 0.150
-
Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma. J Allergy Clin Immunol Pract. 2019 Sep - Oct; 7(7):2447-2449.e2.
Score: 0.038
-
Effects of loratadine and terfenadine on the induced nasal allergic reaction. Arch Otolaryngol Head Neck Surg. 1996 Mar; 122(3):309-16.
Score: 0.030
-
Effects of intranasal azelastine on the response to nasal allergen challenge. Laryngoscope. 2002 Jan; 112(1):47-52.
Score: 0.011